AAAAAA

   
Results: 1-15 |
Results: 15
CHARACTERIZATION OF THE SELECTIVITY AND MECHANISM OF HUMAN CYTOCHROME-P450 INHIBITION BY THE HUMAN IMMUNODEFICIENCY VIRUS-PROTEASE INHIBITOR NELFINAVIR MESYLATE
Authors: LILLIBRIDGE JH LIANG BH KERR BM WEBBER S QUART B SHETTY BV LEE CA
Citation: Jh. Lillibridge et al., CHARACTERIZATION OF THE SELECTIVITY AND MECHANISM OF HUMAN CYTOCHROME-P450 INHIBITION BY THE HUMAN IMMUNODEFICIENCY VIRUS-PROTEASE INHIBITOR NELFINAVIR MESYLATE, Drug metabolism and disposition, 26(7), 1998, pp. 609-616
PHARMACOKINETICS AND METABOLISM OF THE NOVEL ANTICONVULSANT AGENT ,6-DIMETHYLPHENYL)-5-METHYL-3-ISOXAZOLECARBOXAMIDE (D2624) IN RATS AND HUMANS
Authors: MARTIN SW BISHOP FE KERR BM MOOR M MOORE M SHEFFELS P RASHED M SLATTER JG BERTHONCEDILLE L LEPAGE F DESCOMBE JJ PICARD M BAILLIE TA LEVY RH
Citation: Sw. Martin et al., PHARMACOKINETICS AND METABOLISM OF THE NOVEL ANTICONVULSANT AGENT ,6-DIMETHYLPHENYL)-5-METHYL-3-ISOXAZOLECARBOXAMIDE (D2624) IN RATS AND HUMANS, Drug metabolism and disposition, 25(1), 1997, pp. 40-46
THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH RIFAMPIN (RIF) IN HEALTHY-VOLUNTEERS
Authors: YUEN GJ ANDERSON R SANDOVAL T WU E SHETTY BV KERR BM
Citation: Gj. Yuen et al., THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH RIFAMPIN (RIF) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 40-40
THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH KETOCONAZOLE(K) IN HEALTHY-VOLUNTEERS
Authors: KERR BM YUEN GJ SANDOVAL T WU E SHETTY BV ANDERSON R
Citation: Bm. Kerr et al., THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH KETOCONAZOLE(K) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 42-42
FLOW CYTOMETRIC ASSAY OF MODULATION OF P-GLYCOPROTEIN FUNCTION IN WHOLE-BLOOD BY THE MULTIDRUG-RESISTANCE INHIBITOR GG918
Authors: WITHERSPOON SM EMERSON DL KERR BM LLOYD TL DALTON WS WISSEL PS
Citation: Sm. Witherspoon et al., FLOW CYTOMETRIC ASSAY OF MODULATION OF P-GLYCOPROTEIN FUNCTION IN WHOLE-BLOOD BY THE MULTIDRUG-RESISTANCE INHIBITOR GG918, Clinical cancer research, 2(1), 1996, pp. 7-12
PHARMACOKINETICS OF BISMUTH AND RANITIDINE FOLLOWING MULTIPLE DOSES OF RANITIDINE BISMUTH CITRATE
Authors: KOCH KM KERR BM GOODING AE DAVIS IM
Citation: Km. Koch et al., PHARMACOKINETICS OF BISMUTH AND RANITIDINE FOLLOWING MULTIPLE DOSES OF RANITIDINE BISMUTH CITRATE, British journal of clinical pharmacology, 42(2), 1996, pp. 207-211
RECRUITMENT DURING INFECTIOUS-MONONUCLEOSIS OF CD3(-SPECIFIC CYTOTOXIC T-CELLS WHICH RECOGNIZE EPSTEIN-BARR-VIRUS LYTIC ANTIGEN BHRF1()CD4(+)CD8(+) VIRUS)
Authors: WHITE CA CROSS SM KURILLA MG KERR BM SCHMIDT C MISKO IS KHANNA R MOSS DJ
Citation: Ca. White et al., RECRUITMENT DURING INFECTIOUS-MONONUCLEOSIS OF CD3(-SPECIFIC CYTOTOXIC T-CELLS WHICH RECOGNIZE EPSTEIN-BARR-VIRUS LYTIC ANTIGEN BHRF1()CD4(+)CD8(+) VIRUS), Virology, 219(2), 1996, pp. 489-492
IDENTIFICATION OF TYPE B-SPECIFIC AND CROSS-REACTIVE CYTOTOXIC T-LYMPHOCYTE RESPONSES TO EPSTEIN-BARR-VIRUS
Authors: KERR BM KIENZLE N BURROWS JM CROSS S SILINS SL BUCK M BENSON EM COUPAR B MOSS DJ SCULLEY TB
Citation: Bm. Kerr et al., IDENTIFICATION OF TYPE B-SPECIFIC AND CROSS-REACTIVE CYTOTOXIC T-LYMPHOCYTE RESPONSES TO EPSTEIN-BARR-VIRUS, Journal of virology, 70(12), 1996, pp. 8858-8864
PHARMACOKINETICS (PK) AND DYNAMICS (PD) OF THE MULTIDRUG-RESISTANCE (MDR) INHIBITOR GG918 IN HEALTHY-VOLUNTEERS (HVTS)
Authors: KERR BM DAVIS IM WITHERSPOON SM EMERSON DL DALTON WS MANN MB WISSEL PS
Citation: Bm. Kerr et al., PHARMACOKINETICS (PK) AND DYNAMICS (PD) OF THE MULTIDRUG-RESISTANCE (MDR) INHIBITOR GG918 IN HEALTHY-VOLUNTEERS (HVTS), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 40-40
MULTIPLE FORMS OF CYTOCHROME-P450 ARE INVOLVED IN THE METABOLISM OF ONDANSETRON IN HUMANS
Authors: DIXON CM COLTHUP PV SERABJITSINGH CJ KERR BM BOEHLERT CC PARK GR TARBIT MH
Citation: Cm. Dixon et al., MULTIPLE FORMS OF CYTOCHROME-P450 ARE INVOLVED IN THE METABOLISM OF ONDANSETRON IN HUMANS, Drug metabolism and disposition, 23(11), 1995, pp. 1225-1230
PROTECTION FROM PHENYTOIN-INDUCED CONGENITAL-MALFORMATIONS BY COADMINISTRATION OF THE ANTIEPILEPTIC DRUG STIRIPENTOL IN A MOUSE MODEL
Authors: FINNELL RH KERR BM VANWAES M STEWARD RL LEVY RH
Citation: Rh. Finnell et al., PROTECTION FROM PHENYTOIN-INDUCED CONGENITAL-MALFORMATIONS BY COADMINISTRATION OF THE ANTIEPILEPTIC DRUG STIRIPENTOL IN A MOUSE MODEL, Epilepsia, 35(1), 1994, pp. 141-148
FLOW CYTOMETRIC ASSAY OF MODULATION OF P-GLYCOPROTEIN FUNCTION IN CD56+ LEUKOCYTES BY THE MDR INHIBITOR GF120918
Authors: WITHERSPOON SM EMERSON DL KERR BM DALTON WS WISSEL PS
Citation: Sm. Witherspoon et al., FLOW CYTOMETRIC ASSAY OF MODULATION OF P-GLYCOPROTEIN FUNCTION IN CD56+ LEUKOCYTES BY THE MDR INHIBITOR GF120918, Blood, 84(10), 1994, pp. 10000615-10000615
HUMAN LIVER CARBAMAZEPINE METABOLISM - ROLE OF CYP3A4 AND CYP2C8 IN 10,11-EPOXIDE FORMATION
Authors: KERR BM THUMMEL KE WURDEN CJ KLEIN SM KROETZ DL GONZALEZ FJ LEVY RH
Citation: Bm. Kerr et al., HUMAN LIVER CARBAMAZEPINE METABOLISM - ROLE OF CYP3A4 AND CYP2C8 IN 10,11-EPOXIDE FORMATION, Biochemical pharmacology, 47(11), 1994, pp. 1969-1979
DIFFERENCES IN THE PATTERNS OF PHENYTOIN-INDUCED MALFORMATIONS FOLLOWING STIRIPENTOL COADMINISTRATION IN 3 INBRED MOUSE STRAINS
Authors: FINNELL RH VANWAES M MUSSELMAN A KERR BM LEVY RH
Citation: Rh. Finnell et al., DIFFERENCES IN THE PATTERNS OF PHENYTOIN-INDUCED MALFORMATIONS FOLLOWING STIRIPENTOL COADMINISTRATION IN 3 INBRED MOUSE STRAINS, Reproductive toxicology, 7(5), 1993, pp. 439-448
CTL CLONES FROM AN INFECTIOUS-MONONUCLEOSIS PATIENT ARE CD3-BARR-VIRUS LYTIC PROTEIN BHRF1(CD4+CD8+ AND RECOGNIZE THE EPSTEIN)
Authors: JACOB CA CROSS SM KERR BM SCHMIDT C MISKO IS MOSS DJ
Citation: Ca. Jacob et al., CTL CLONES FROM AN INFECTIOUS-MONONUCLEOSIS PATIENT ARE CD3-BARR-VIRUS LYTIC PROTEIN BHRF1(CD4+CD8+ AND RECOGNIZE THE EPSTEIN), Journal of leukocyte biology, 1993, pp. 47-47
Risultati: 1-15 |